Canonical: https://ownershiptrace.com/13f/companies/832

# Who owns Adaptive Biotechnologies Corp (ADPT)? Elite investor 13F holders

7 tracked elite investors reported holding Adaptive Biotechnologies Corp as of 2026-06-30, including Viking Global Investors, D.E. Shaw, Tudor Investment, Renaissance Technologies LLC, Polen Capital Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Viking Global Investors](https://ownershiptrace.com/13f/investors/81) | ADAPTIVE BIOTECHNOLOGIES COR | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 643365037.00 USD | 29993708.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/1103804/0001103804-26-000006-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | ADAPTIVE BIOTECHNOLOGIES COR | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 99224675.00 USD | 4625859.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | ADAPTIVE BIOTECHNOLOGIES COR | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 11657753.00 USD | 543485.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | ADAPTIVE BIOTECHNOLOGIES COR | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 6495060.00 USD | 302800.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Polen Capital Management](https://ownershiptrace.com/13f/investors/61) | ADAPTIVE BIOTECHNOLOGIES COR | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 2197703.00 USD | 102457.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1034524/0001172661-26-003035-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | ADAPTIVE BIOTECHNOLOGIES COR | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1603001.00 USD | 74732.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |
| [Bridgewater Associates](https://ownershiptrace.com/13f/investors/8) | ADAPTIVE BIOTECHNOLOGIES COR | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 859866.00 USD | 40087.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1350694/0001350694-26-000003-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)